The healthcare industry is undergoing a significant shift towards a patient-centric model, with a focus on specialty pharmaceuticals. This shift is driven by the rapid growth of the specialty pharmaceutical market, which is creating structural changes across the healthcare landscape. The report discusses the manufacturing of specialty products and biologics, as well as the distribution and related services of specialty pharmaceuticals. The report also covers the insurance and reimbursement for specialty pharmaceuticals, marketing and post-clinical monitoring services, and the authors of the report.
